Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT00244894
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Confirmed diagnosis of prostate cancer
* Hot flash score ≥ 4 per day
* Prior or concurrent treatment with 1 of the following :
* Bilateral orchiectomy
* Gonadotropin releasing-hormone (GnRH) agonist or antagonist therapy
* Antiandrogen therapy
PATIENT CHARACTERISTICS:
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* No mental impairment
PRIOR CONCURRENT THERAPY:
Chemotherapy
* No concurrent chemotherapy
Endocrine therapy
* See Disease Characteristics
* More than 4 weeks since prior estrogen or progestational drugs
Surgery
* See Disease Characteristics
* No prior placement of a pacemaker or other implantable electrical device
Other
* More than 4 weeks since prior gabapentin
* No concurrent antidepressant drugs
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00244894
Study Brief:
Protocol Section:
NCT00244894